Junmin Quan

2.0k total citations
58 papers, 1.5k citations indexed

About

Junmin Quan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Junmin Quan has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 15 papers in Organic Chemistry and 11 papers in Oncology. Recurrent topics in Junmin Quan's work include interferon and immune responses (8 papers), Chemical Synthesis and Analysis (7 papers) and Asymmetric Synthesis and Catalysis (6 papers). Junmin Quan is often cited by papers focused on interferon and immune responses (8 papers), Chemical Synthesis and Analysis (7 papers) and Asymmetric Synthesis and Catalysis (6 papers). Junmin Quan collaborates with scholars based in China, Hong Kong and United States. Junmin Quan's co-authors include Zhen Yang, Chen Shen, Hong Sun, Qinkai Li, Tao Wang, Jun Xu, Yun‐Dong Wu, Qinhong Luo, Zhengshuang Xu and Chao Che and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Junmin Quan

57 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Junmin Quan 825 441 226 217 150 58 1.5k
Remigiusz Serwa 1.2k 1.4× 539 1.2× 214 0.9× 103 0.5× 245 1.6× 56 1.8k
Rongshi Li 1.0k 1.2× 789 1.8× 339 1.5× 121 0.6× 88 0.6× 44 2.2k
Daniel Dauzonne 862 1.0× 585 1.3× 275 1.2× 81 0.4× 157 1.0× 70 1.7k
Armando G. Villaseñor 537 0.7× 355 0.8× 139 0.6× 153 0.7× 39 0.3× 21 1.1k
Athanasios Papakyriakou 1.0k 1.2× 410 0.9× 681 3.0× 372 1.7× 65 0.4× 95 2.1k
Sangita B. Patel 1.1k 1.3× 546 1.2× 341 1.5× 171 0.8× 62 0.4× 39 1.7k
Elizabeth A. Lunney 1.0k 1.3× 583 1.3× 217 1.0× 60 0.3× 234 1.6× 59 1.8k
Bing Xiong 1.5k 1.9× 566 1.3× 243 1.1× 113 0.5× 63 0.4× 143 2.3k
J. Richard Miller 836 1.0× 260 0.6× 214 0.9× 176 0.8× 122 0.8× 35 1.6k
Paul Bamborough 1.8k 2.2× 468 1.1× 330 1.5× 191 0.9× 109 0.7× 58 2.5k

Countries citing papers authored by Junmin Quan

Since Specialization
Citations

This map shows the geographic impact of Junmin Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junmin Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junmin Quan more than expected).

Fields of papers citing papers by Junmin Quan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junmin Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junmin Quan. The network helps show where Junmin Quan may publish in the future.

Co-authorship network of co-authors of Junmin Quan

This figure shows the co-authorship network connecting the top 25 collaborators of Junmin Quan. A scholar is included among the top collaborators of Junmin Quan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junmin Quan. Junmin Quan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Weilin, Yuxuan Zhao, Wenjing Qin, et al.. (2025). Targeting USP1 Potentiates Radiation‐Induced Type I IFN‐Dependent Antitumor Immunity by Enhancing Oligo‐Ubiquitinated SAR1A‐Mediated STING Trafficking and Activation. Advanced Science. 12(15). e2412687–e2412687. 1 indexed citations
2.
Quan, Junmin, et al.. (2024). Feedback activation of CD73-Adenosine axis attenuates the antitumor immunity of STING pathway. Biochemical and Biophysical Research Communications. 708. 149814–149814. 1 indexed citations
3.
Su, Qiang, et al.. (2024). Enhancing RNA-seq bias mitigation with the Gaussian self-benchmarking framework: towards unbiased sequencing data. BMC Genomics. 25(1). 904–904. 1 indexed citations
4.
Wang, Xiaoquan, Qinhong Luo, Daoyuan Chen, et al.. (2023). Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation. Nature Communications. 14(1). 6132–6132. 31 indexed citations
5.
Li, Qinkai, et al.. (2023). Development of a novel anti-inflammatory recombinant uricase with extended half-life for gout therapy. Biochemical and Biophysical Research Communications. 666. 115–121. 5 indexed citations
6.
Zheng, Nan, Chi‐Tai Yeh, Chien‐Ming Lee, et al.. (2022). Identification and semisynthesis of (−)-anisomelic acid as oral agent against SARS-CoV-2 in mice. National Science Review. 9(11). 37–57. 4 indexed citations
7.
Chen, Yaqi, et al.. (2022). Identification of DNA aptamers that specifically targets EBV+ nasopharyngeal carcinoma via binding with EphA2/CD98hc complex. Biochemical and Biophysical Research Communications. 608. 135–141. 4 indexed citations
8.
Wu, Weijian, Huiying Xu, Jiaxin Wu, et al.. (2022). Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination. Cellular Oncology. 45(6). 1347–1361. 4 indexed citations
9.
Luo, Qinhong, et al.. (2019). STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity. Cancer Letters. 450. 110–122. 59 indexed citations
10.
Shen, Chen, et al.. (2018). Structural basis for dimerization of the death effector domain of the F122A mutant of Caspase-8. Scientific Reports. 8(1). 16723–16723. 20 indexed citations
11.
12.
Shi, Yanxia, et al.. (2014). Identification of Green Tea Catechins as Potent Inhibitors of the Polo‐Box Domain of Polo‐Like kinase 1. ChemMedChem. 10(1). 158–163. 23 indexed citations
13.
Wang, Tao, et al.. (2014). Crystal structure of the polo-box domain of polo-like kinase 2. Biochemical and Biophysical Research Communications. 456(3). 780–784. 11 indexed citations
14.
Chen, Tao, et al.. (2013). Optical imaging of non-fluorescent nanodiamonds in live cells using transient absorption microscopy. Nanoscale. 5(11). 4701–4701. 24 indexed citations
15.
Xu, Jun, Chen Shen, Tao Wang, & Junmin Quan. (2013). Structural basis for the inhibition of Polo-like kinase 1. Nature Structural & Molecular Biology. 20(9). 1047–1053. 94 indexed citations
16.
Wang, Jing, Fei Lu, Qi Ren, et al.. (2011). Novel Histone Demethylase LSD1 Inhibitors Selectively Target Cancer Cells with Pluripotent Stem Cell Properties. Cancer Research. 71(23). 7238–7249. 182 indexed citations
17.
Yang, Yun‐Fang, Ting Shi, Xinhao Zhang, et al.. (2011). Theoretical studies on the mechanism and stereoselectivity of Rh(Phebox)-catalyzed asymmetric reductive aldol reaction. Organic & Biomolecular Chemistry. 9(16). 5845–5845. 25 indexed citations
18.
Zhong, Hanbing, Haixia Zou, Mikhail V. Semënov, et al.. (2009). Characterization and development of novel small-molecules inhibiting GSK3 and activating Wntsignaling. Molecular BioSystems. 5(11). 1356–1360. 34 indexed citations
19.
Yang, Hongbo, Chao Che, Haixia Zou, et al.. (2009). Identifying Tumor Cell Growth Inhibitors by Combinatorial Chemistry and Zebrafish Assays. PLoS ONE. 4(2). e4361–e4361. 24 indexed citations
20.
Wu, Min, Leigh Ann Higa, Nadia J. Gavrilova, et al.. (2006). L2DTL/CDT2 and PCNA Interact with p53 and Regulate p53 Polyubiquitination and Protein Stability through MDM2 and CUL4A/DDB1 Complexes. Cell Cycle. 5(15). 1719–1729. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026